Compound with possible N → N coordination bond: Synthesis, crystal structure and electronic structure analysis

Neutral Cyclic Nitreones: Electronic Structure Analysis Reveals an Unorthodox Perspective of Several Zwitterionic Heterocyclic Species

Nitreones are compounds with the general formula L → N+ ← L'. These compounds exhibit medicinal properties and have found applications in phase transfer catalysis. A few nitreones are cyclic; protonated cycloguanil (an antimalarial agent) is the most prominent example. Recently, a few more cyclic compounds were experimentally reported, in which the central N+ was shown to exhibit nitreone character. This led to attention being paid to the chemistry of neutral cyclic nitreones. A thorough literature search led to two sets of cyclic nitreones: C → N ← C type and P → N ← P type. In this work, we report quantum chemical analysis in exploring the electronic structure of neutral cyclic nitreones. Molecular orbital analysis, electron density analysis, charge, electron localization function (ELF), complexation energy values, and Tolman electronic parameter (TEP) all indicate that the studied compounds do carry nitrogen in the N(I) oxidation state and the two lone pairs are at the central nitrogen; thus, they qualify to be considered as cyclic nitreones.

Identification of CYP3A4 inhibitors as potential anti-cancer agents using pharmacoinformatics approach

Biguanide derivatives exhibit a wide variety of therapeutic applications, including anti-cancer effects. Metformin is an effective anti-cancer agent against breast cancer, lung cancer, and prostate cancer. In the crystal structure (PDB ID: 5G5J), it was found that metformin is found in the active site of CYP3A4, and the associated anti-cancer effect was explored. Taking clues from this work, pharmacoinformatics research has been carried out on a series of known and virtual biguanide, guanylthiourea (GTU), and nitreone derivatives. This exercise led to the identification of more than 100 species that exhibit greater binding affinity toward CYP3A4 in comparison to that of metformin. Selected six molecules were subjected to molecular dynamics simulations, and the results are presented in this work.